SCHEMBL5653371

SCHEMBL5653371

COc1cc2nncc(-n3ncc4ccccc43)c2cc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 12/20 0.47
PDGFRB P09619 1/20 0.42
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
NQO2 P16083 1/20 0.39
PDPK1 O15530 1/20 0.39
USP2 O75604 1/20 0.38
GLA P06280 1/20 0.38
TSHR P16473 1/20 0.38
ALOX12 P18054 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4977732 0.84 IRAK4 (0.42) PDE10APDGFRBCYP1A2CYP3A4CYP2C19
SCHEMBL4778828 0.82 PDE10A (0.43) PDE10APDGFRBMEN1ALDH1A1KMT2A
SCHEMBL5652542 0.81 PDGFRB (0.47) PDE10APDGFRBCYP3A4
SCHEMBL4977487 0.81 PDGFRB (0.50) PDE10APDGFRBMEN1KMT2ANPC1
SCHEMBL4982681 0.81 PDGFRB (0.44) PDE10APDGFRB
SCHEMBL5651961 0.81 PDE10A (0.56) PDE10APDGFRBKDM4ENPC1MAPT
SCHEMBL5302614 0.80 PDE10A (0.47) PDE10APDGFRBMEN1ALDH1A1KMT2A
SCHEMBL5651040 0.79 FLT1 (0.41) PDE10APDGFRBPDPK1
SCHEMBL5653771 0.79 KDR (0.41) PDE10APDGFRBPDPK1
SCHEMBL4979935 0.78 PDE10A (0.45) PDE10APDGFRBALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070265270-A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors MEMORY PHARMACEUTICALS CORPORATION 2007-11-15 US disclosed
US-20070265270-A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors MEMORY PHARMACEUTICALS CORPORATION 2007-11-15 US disclosed
US-20070265270-A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors MEMORY PHARMACEUTICALS CORPORATION 2007-11-15 US disclosed
WO-2007098214-A1 CINNOLINE DERIVATIVES AS PHOSPHODIESTERASE 10 INHIBITORS AMGEN INC. (US) 2007-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265270-A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors PDE7A, PDE10A, PDE7B PDE10A 2/4885PDGFRB 3311/4885MEN1 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.